ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Expression pattern of miR-193a, miR-451 and their targets in colorectal cancer tissues

7th World Congress on Molecular Pathology

Afraa Mamoori, Vinod Gopalan and Alfred King Yin Lam

Griffith University, Australia

Posters & Accepted Abstracts: J Clin Exp Pathol

DOI: 10.4172/2161-0681.C1.026

Abstract
MicroRNAs (miRNAs) play a crucial role in the process of coding gene expression, cells differentiation and cellular identity. Emerging data suggests that miR-193a-3P and miR-451 play important roles in colorectal cancer by targeting KRAS and MIF genes respectively. This study aimed to investigate the expression profiling of miR-193a-3P and miR-451 and identify the expression level of their target genes in colorectal cancer tissues. A total of 60 fresh frozen human tissue specimens (matched cancer and noncancer tissues) were used in this study. The expression pattern of miR-193a-3P and miR-451 in non-cancer tissue and primary cancer was measured by using quantitative Real-Time PCR. The expression level of miR-193a-3P target gene (KRAS) and miR-451 target gene (MIF) was assessed by immunohistochemical study. Also, the expression pattern of these miRNAs was correlated to different pathological and clinical parameters. Majority of colorectal cancer tissues showed down regulation of miR-451 (83.3%) and miR- 193a-3P (68.3%) when compared to their matched non-cancer tissues. miR -193a-3P showed up regulation in 26.7% of the cases (fold change ranged from 1.6 to 39.12). Low expression of miR-193a-3P showed significant correlation with early stages of tumor (stage I and II) when compared to the advance stages (stage III and IV) (70.7%, n=29/41 versus 29.3%, n=12/41, P value=0.044). This study showed significant correlation of miR-451down-regulation with recurrence of tumor and pre-existing adenoma when compared to the high expression (26.0%, n=13/50 versus 0.0%, n=0/5, P value=0.013) (46.0%, n=23/50 versus 0.0%, n=0/5, P value<0.05) respectively. Immunohistochemical study reveals more strong and moderate staining for MIF protein which is correlated inversely with miR-451 down regulation (61.6% with moderate and strong staining versus 36.7% with low and null protein staining). Moreover, down regulation of miR-451 was positively correlated with low miR-193a expression (p value=0.01). Furthermore, strong expression pattern of MIF protein correlate positively with strong KRAS protein expression (p value=0.041). Dysregulation of miR-193a and miR-451 in this study suggests that these miRNAs could play an important role in colorectal cancer pathogenesis. The significant correlation between the expression patterns of these miRNAs and the significant correlation between their target genes (KRAS/MIF) suggesting that there is interaction between the signaling pathways they involved. Additional studies with increase sample size and in vitro studies are required to further validate the results.
Biography

Email: afraamahdijawad.mamoori@griffithuni.edu.au

Top